1,3,4,5-TETRAHYDRO-3-(3-((((7S)-3-HYDROXY-4-METHOXYBICYCLO(4.2.0)OCTA-1,3,5-TRIEN-7-YL)METHYL)METHYLAMINO)PROPYL)-7,8-DIMETHOXY-2H-3-BENZAZEPIN-2-ONE
UNII H8NU2J55GH
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,3,4,5-tetrahydro-3-(3-((((7s)-3-hydroxy-4-methoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-7,8-dimethoxy-2h-3-benzazepin-2-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H8NU2J55GH.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 304464-98-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H34N2O5 CKPWHHKAGYLHEU-HXUWFJFHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,3,4,5-tetrahydro-3-(3-((((7s)-3-hydroxy-4-methoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-7,8-dimethoxy-2h-3-benzazepin-2-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.